本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Artiva Biotherapeutics, Inc.

5.10
-0.5000-8.93%
盘后5.100.00000.00%18:23 EDT
成交量:11.22万
成交额:58.24万
市值:1.24亿
市盈率:-0.45
高:5.86
开:5.68
低:4.81
收:5.60
数据加载中...

公司资料

公司名字:
Artiva Biotherapeutics, Inc.
交易所:
NASDAQ
成立时间:
2019
员工人数:
82
公司地址:
5505 Morehouse Drive,Suite 100,San Diego,California,United States
邮编:
92121
电话:
传真:
- -
简介:
Artiva Biotherapeutics, Inc.于2019年2月14日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,专注于为患有破坏性自身免疫性疾病和癌症的患者开发基于自然杀伤(NK)细胞的疗法。

董事

名称
职位
Fred Aslan
President, Chief Executive Officer and Director
Brian Daniels
Chairperson of the Board
Diego Miralles
Director
Elizabeth Hougen
Director
James Park
Director
Laura Bessen
Director
Laura Stoppel
Director
Yong Jun Huh
Director
Yvonne Yamanaka
Director

股东

名称
职位
Fred Aslan
President, Chief Executive Officer and Director
Jennifer Bush
Chief Operating Officer, Chief Legal Officer, Corporate Secretary and Compliance Officer
Heather Raymon
Senior Vice President of Research and Early Development
Neha Krishnamohan
Chief Financial Officer and Executive Vice President of Corporate Development
Christopher P. Horan
Chief Technical Operations Officer
Thorsten Graef
Chief Medical Officer